Cingulate Inc.
NASDAQ:CINGBiotechnology
-$0.05 today
- Market cap
- $76.46M
- Beta
- -0.91
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$5.10
Volume 0.95M
Average 0.46M
CING Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Cingulate Inc.NASDAQ: CING
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments remains negative
Q1 FY2026 short-term investments was $0, compared with $0 a year earlier.
Context
- Short-term investments amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Short-term investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 933 | — |
Short-term Investments vs competitors
How CING compares with its peers on the latest reported figures
- CING's Mar 2026 short-term investments of $0 is the highest of the 2 companies compared; the peer median is $0.
- Short-term investments amounts to 0.0% of total assets for CING, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CING) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CING. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 16.49M | 5.36M | 52.42K | 12.21M | 10.95M |
| Short-term Investments | 933 | 0 | 0 | 0 | 0 |
| Net Receivables | 690.25K | 234.43K | 14.62K | 26.33K | 8.01K |
| Inventory | 0 | 100.34K | 0 | 0 | 0 |
| Other Current Assets | 1.7M | 1.64M | 490.86K | 368.29K | 80.08K |
| Total Current Assets | 18.88M | 7.87M | 578.59K | 12.66M | 12.01M |
| Property, Plant & Equipment (Net) | 4M | 3.54M | 2.91M | 2.2M | 3.07M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.36B | 5.91B | 0 | 0 | 0 |
| Other Non-current Assets | (1.36B) | (5.91B) | 0 | 0 | 0 |
| Total Non-current Assets | 4M | 3.54M | 2.91M | 2.2M | 3.07M |
| Total Assets | 22.89M | 11.41M | 3.49M | 14.86M | 15.07M |
| Account Payables | 264.69K | 762.36K | 5.2M | 1.27M | 2.04M |
| Short-term Debt | 310.69K | 5M | 3M | 2.53M | 6.3M |
| Tax Payables | 0 | 0 | 120.57K | 200K | 0 |
| Deferred Revenue | 601.3K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (336.67K) | 719.01K | 593.02K | 355.48K | 455.18K |
| Total Current Liabilities | 1.18M | 7.01M | 10.23M | 4.97M | 10.31M |
| Long-term Debt | 0 | 0 | 0 | 2.44M | 1.15M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 866.04K | 510.24K | 135.1K | 2.44M | 2.25M |
| Total Liabilities | 2.04M | 7.52M | 10.36M | 7.41M | 12.56M |
| Common Stock | 1.13K | 61 | 10 | 340 | 725 |
| Retained Earnings | (51.73M) | (69.41M) | (92.94M) | (108.49M) | (132.38M) |
| Accumulated OCI | 165 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 20.84M | 3.88M | (6.87M) | 7.46M | 2.51M |
| Total Debt | 1.19M | 5.87M | 3.51M | 5.1M | 8.79M |
| Net Debt | (15.3M) | 509.77K | 3.46M | (7.11M) | (2.17M) |
Cingulate Inc.
NASDAQ:CING
Intrinsic Alpha fair value
Locked
Current Price
$5.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.